Blog

ImmunityBio IBRX is moving from a U.S.-led launch to a broader international rollout. Authorizations now span the United States, the United Kingdom, the European Union, Saudi Arabia, and Macau

ImmunityBio IBRX has delivered a stunning rerating in 2026. After a move like this, investors often stop debating the story and start debating the price. That shift matters because valuation can

ImmunityBio IBRX enters 2026 with a commercial story that is unusually concentrated. Anktiva is the company’s first marketed product, and it is already the clear topline driver.

What matters now is

Senseonics SENS recently announced the European launch of its groundbreaking Eversense 365 CGM system, the world’s first continuous glucose monitoring (CGM) system designed to last an entire year

iShares MSCI South Korea ETF EWY is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and has moved up 183.68% from its 52-week low price of $55.33 per share.

Brent crude, the global benchmark, climbed above $106 per barrel, gaining nearly 7% over the past five days as oil rose this Monday as stalled Iran talks kept shipment flows through the Strait of

Domino's Pizza, Inc. DPZ reported first-quarter fiscal 2026 results, with earnings missing the Zacks Consensus Estimate and decreasing on a year-over-year basis. However, total revenues also missed

STMicroelectronics (STM) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue

Gorman-Rupp (GRC) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with

Investors might want to bet on Docebo Inc. (DCBO), as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum

Texas Instruments (TXN) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue

Investors might want to bet on Cass Information Systems (CASS), as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price

Eni S.p.A. E on April 20, 2026 announced a significant gas discovery at the Geliga-1 exploration well in the Kutei Basin, offshore Indonesia. Following the announcement, E shares rose 2.83% to

Bread Financial Holdings, Inc. BFH reported first-quarter 2026 operating income of $4.18 per share, outperforming the Zacks Consensus Estimate by 39.3%. The bottom line rose 49% year over year.

Newell Brands Inc. NWL is expected to register a year-over-year decline in the top and bottom lines when it reports first-quarter 2026 results on May 1, before the opening bell. The Zacks Consensus

Trane Technologies plc TT is set to report first-quarter 2026 earnings on April 30, before the opening bell.

The company’s earnings surprise history has been impressive. It surpassed the Zacks

Amazon AMZN is scheduled to report first-quarter 2026 results on April 29.For the first quarter, the company anticipates net sales between $173.5 billion and $178.5 billion, implying 11% to 15%

Novartis NVS announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given a positive opinion recommending marketing authorization for

Kinsale Capital Group, Inc. KNSL delivered first-quarter 2026 net operating earnings of $5.11 per share, which outpaced the Zacks Consensus Estimate by 8.7%. The bottom line increased 37.7% year

Investment banker Goldman Sachs recently raised its price target for UnitedHealth Group Incorporated (UNH) shares from $400 to $435, citing the company’s increased full-year guidance, announced in

T-Mobile, US, Inc. TMUS is set to report first-quarter 2026 results on April 28, after the closing bell. In the trailing four quarters, the company delivered an earnings surprise of 5.83%, beating

Brinker International, Inc. EAT is scheduled to report third-quarter fiscal 2026 results on April 29.

EAT’s earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, the

The first-quarter 2026 reporting cycle for the Medical sector is about to accelerate, as most companies are scheduled to release results over the next two weeks. The earnings season for the drug and

BHP Group Limited BHP and Vale S.A. VALE are among the world’s largest iron ore producers and diversified miners, making them competitors in the global metals and mining sector. Both companies are

Shares of Organon OGN jumped 16% in pre-market trading after the company and India’s Sun Pharmaceutical Industries Limited jointly announced a definitive agreement. Per the agreement, Sun Pharma